Skip to main content

Table 5 Demographic and clinical data of patients without (C-) or with (C+) post-stroke cognitive decline. F, female; M, male

From: Increased serum QUIN/KYNA is a reliable biomarker of post-stroke cognitive decline

  C- patients (n = 10) C+ patients (n = 13) P
Gender (F/M) 4/6 5/8 1
Mean age ± SD (years) 64.7 ± 13.3 69.4 ± 17.8 0.38
Diabetes 1 2 1
Hypertension 5 8 0.685
Fibrinolysis 8 12 0.5596
Thrombectomy 5 6 1
Anterior circulation 7 13 0.4561
Posterior circulation 3 0 0.0678
Cardio-embolic 4 6 1
Atheroma 4 5 1
Undetermined 2 2 1
\